524
Views
34
CrossRef citations to date
0
Altmetric
Inflammatory bowel disease

Dipeptidyl peptidase-4 inhibitor anagliptin facilitates restoration of dextran sulfate sodium-induced colitis

, , , , , , , , , , , , , & show all
Pages 1152-1159 | Received 03 May 2013, Accepted 02 Aug 2013, Published online: 19 Sep 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Ahmed Al-Dwairi, Tamara E Alqudah, Othman Al-Shboul, Mohammad Alqudah, Ayman G Mustafa & Mahmoud A Alfaqih. (2018) Glucagon-like peptide-1 exerts anti-inflammatory effects on mouse colon smooth muscle cells through the cyclic adenosine monophosphate/nuclear factor-κB pathway in vitro. Journal of Inflammation Research 11, pages 95-109.
Read now
Masanobu Matsushita, Osamu Watanabe, Takafumi Ando, Osamu Maeda, Ryoji Miyahara, Masanao Nakamura, Takeshi Yamamura, Hidemi Goto & Yoshiki Hirooka. (2016) Small intestine morphology and recovery after drug-induced colitis in proglucagon-derived peptides knockout mice. Cogent Medicine 3:1.
Read now
Shinya Nishio, Mariko Abe & Hiroyuki Ito. (2015) Anagliptin in the treatment of type 2 diabetes: safety, efficacy, and patient acceptability. Diabetes, Metabolic Syndrome and Obesity 8, pages 163-171.
Read now

Articles from other publishers (31)

Zhong Zhang, Mengqiu Yan, Wen Li, Wanchao Chen, Yanfang Liu, Di Wu, Shuai Zhou, Jingsong Zhang & Yan Yang. (2023) Anti-inflammatory Activity of Polysaccharide from Spent Substrate of Lentinula Edode Based on Extraction of High Pressure-Complex Enzyme. Journal of Polymers and the Environment.
Crossref
Chunli Hu, Shengtao Liao, Lin Lv, Chuanfei Li & Zhechuan Mei. (2023) Intestinal Immune Imbalance is an Alarm in the Development of IBD. Mediators of Inflammation 2023, pages 1-17.
Crossref
Shinichiro Shinzaki, Toshiyuki Sato & Hirokazu Fukui. (2023) Antidiabetic drugs for IBD: a long but promising road ahead for drug repositioning to target intestinal inflammation. Journal of Gastroenterology 58:6, pages 598-599.
Crossref
Bo Zhang, Daoyuan Ren, Aiqing Zhao, Hongjun Shao, Ting Li, Pengfei Niu, Yan Zhao & Xingbin Yang. (2022) Eurotium cristatum Exhibited Anti-Colitis Effects via Modulating Gut Microbiota-Dependent Tryptophan Metabolism . Journal of Agricultural and Food Chemistry 70:51, pages 16164-16175.
Crossref
Xiaojie Lu, Yue Jing, Naisheng Zhang & Yongguo Cao. (2022) Eurotium cristatum , a Probiotic Fungus from Fuzhuan Brick Tea, and Its Polysaccharides Ameliorated DSS-Induced Ulcerative Colitis in Mice by Modulating the Gut Microbiota . Journal of Agricultural and Food Chemistry 70:9, pages 2957-2967.
Crossref
Jie Huang, Xinxin Liu, Yingying Wei, Xinlu Li, Shupei Gao, Lingli Dong, Xiaoquan Rao & Jixin Zhong. (2022) Emerging Role of Dipeptidyl Peptidase-4 in Autoimmune Disease. Frontiers in Immunology 13.
Crossref
Robert H. Mills, Parambir S. Dulai, Yoshiki Vázquez-Baeza, Consuelo Sauceda, Noëmie Daniel, Romana R. Gerner, Lakshmi E. Batachari, Mario Malfavon, Qiyun Zhu, Kelly Weldon, Greg Humphrey, Marvic Carrillo-Terrazas, Lindsay DeRight Goldasich, MacKenzie Bryant, Manuela Raffatellu, Robert A. Quinn, Andrew T. Gewirtz, Benoit Chassaing, Hiutung Chu, William J. Sandborn, Pieter C. Dorrestein, Rob Knight & David J. Gonzalez. (2022) Multi-omics analyses of the ulcerative colitis gut microbiome link Bacteroides vulgatus proteases with disease severity. Nature Microbiology 7:2, pages 262-276.
Crossref
Simone E. JaenischCatherine A. AbbottMark D. GorrellPeter BamptonRoss N. ButlerRoger Yazbeck. (2022) Circulating Dipeptidyl Peptidase Activity Is a Potential Biomarker for Inflammatory Bowel Disease. Clinical and Translational Gastroenterology 13:1, pages e00452.
Crossref
Hubert Zatorski, Maciej Salaga, Marta Zielińska, Anna Mokrowiecka, Damian Jacenik, Wanda Małgorzata Krajewska, Ewa Małecka-Panas & Jakub Fichna. (2021) Colonic inflammation induces changes in glucose levels through modulation of incretin system. Pharmacological Reports 73:6, pages 1670-1679.
Crossref
Francisco Jorge Melo, Pedro Pinto-Lopes, Maria Manuela Estevinho & Fernando Magro. (2021) The Role of Dipeptidyl Peptidase 4 as a Therapeutic Target and Serum Biomarker in Inflammatory Bowel Disease: A Systematic Review. Inflammatory Bowel Diseases 27:7, pages 1153-1165.
Crossref
Marina R. Fouad, Rania M. Salama, Hala F. Zaki & Ayman E. El-Sahar. (2021) Vildagliptin attenuates acetic acid-induced colitis in rats via targeting PI3K/Akt/NFκB, Nrf2 and CREB signaling pathways and the expression of lncRNA IFNG-AS1 and miR-146a. International Immunopharmacology 92, pages 107354.
Crossref
Meng-meng Ning, Wen-ji Yang, Wen-bo Guan, Yi-pei Gu, Ying Feng & Ying Leng. (2020) Dipeptidyl peptidase 4 inhibitor sitagliptin protected against dextran sulfate sodium-induced experimental colitis by potentiating the action of GLP-2. Acta Pharmacologica Sinica 41:11, pages 1446-1456.
Crossref
Laurie L. Baggio, Elodie M. Varin, Jacqueline A. Koehler, Xiemin Cao, Yuliya Lokhnygina, Susanna R. Stevens, Rury R. Holman & Daniel J. Drucker. (2020) Plasma levels of DPP4 activity and sDPP4 are dissociated from inflammation in mice and humans. Nature Communications 11:1.
Crossref
Fubao Huang, Mengmeng Ning, Kai Wang, Jia Liu, Wenbo Guan, Ying Leng & Jianhua Shen. (2019) Discovery of Highly Polar β-Homophenylalanine Derivatives as Nonsystemic Intestine-Targeted Dipeptidyl Peptidase IV Inhibitors. Journal of Medicinal Chemistry 62:23, pages 10919-10925.
Crossref
Tiansheng Wang, Jeff Y. Yang, John B. Buse, Virginia Pate, Huilin Tang, Edward L. Barnes, Robert S. Sandler & Til Stürmer. (2019) Dipeptidyl Peptidase 4 Inhibitors and Risk of Inflammatory Bowel Disease: Real-world Evidence in U.S. Adults. Diabetes Care 42:11, pages 2065-2074.
Crossref
Hubert Zatorski, Maciej Sałaga & Jakub Fichna. (2019) Role of glucagon-like peptides in inflammatory bowel diseases—current knowledge and future perspectives. Naunyn-Schmiedeberg's Archives of Pharmacology 392:11, pages 1321-1330.
Crossref
Yunjuan Zhao. (2019) CD26 in autoimmune diseases: The other side of “moonlight protein”. International Immunopharmacology 75, pages 105757.
Crossref
M Salaga, A Binienda, P Draczkowski, P Kosson, R Kordek, K Jozwiak & J Fichna. (2018) Novel peptide inhibitor of dipeptidyl peptidase IV (Tyr-Pro-D-Ala-NH2) with anti-inflammatory activity in the mouse models of colitis. Peptides 108, pages 34-45.
Crossref
Marta Olivares, Valentina Schüppel, Ahmed M. Hassan, Martin Beaumont, Audrey M. Neyrinck, Laure B. Bindels, Alfonso Benítez-Páez, Yolanda Sanz, Dirk Haller, Peter Holzer & Nathalie M. Delzenne. (2018) The Potential Role of the Dipeptidyl Peptidase-4-Like Activity From the Gut Microbiota on the Host Health. Frontiers in Microbiology 9.
Crossref
Gwendolyn Vliegen & Ingrid De Meester. 2018. Immunity and Inflammation in Health and Disease. Immunity and Inflammation in Health and Disease 133 147 .
Lihua Duan, Xiaoquan Rao, Zachary Braunstein, Amelia C. Toomey & Jixin Zhong. (2017) Role of Incretin Axis in Inflammatory Bowel Disease. Frontiers in Immunology 8.
Crossref
Chin-Hsiao Tseng. (2017) Sitagliptin and oral cancer risk in type 2 diabetes patients. Oncotarget 8:57, pages 96753-96760.
Crossref
Yen-Cheng Chen, Ching-Chun Ho, Chih-Hsun Yi, Xiu-Zhu Liu, Tzu-Ting Cheng & Chen-Fuh Lam. (2017) Exendin-4, a glucagon-like peptide-1 analogue accelerates healing of chronic gastric ulcer in diabetic rats. PLOS ONE 12:11, pages e0187434.
Crossref
Maciej Salaga, Anna Mokrowiecka, Marta Zielinska, Ewa Malecka-Panas, Radzislaw Kordek, Elzbieta Kamysz & Jakub Fichna. (2017) New Peptide Inhibitor of Dipeptidyl Peptidase IV, EMDB-1 Extends the Half-Life of GLP-2 and Attenuates Colitis in Mice after Topical Administration. Journal of Pharmacology and Experimental Therapeutics 363:1, pages 92-103.
Crossref
Kaushik MukherjeeSandra L. KavalukasAdrian Barbul. (2016) Nutritional Aspects of Gastrointestinal Wound Healing. Advances in Wound Care 5:11, pages 507-515.
Crossref
Claus H. Bang-Berthelsen, Thomas L. Holm, Charles Pyke, Lotte Simonsen, Rolf Søkilde, Flemming Pociot, R. Scott Heller, Lasse Folkersen, Peter H. Kvist, Malene Jackerott, Jan Fleckner, Mogens Vilién, Lotte B. Knudsen, Anders Heding & Klaus S. Frederiksen. (2016) GLP-1 Induces Barrier Protective Expression in Brunnerʼs Glands and Regulates Colonic Inflammation. Inflammatory Bowel Diseases 22:9, pages 2078-2097.
Crossref
Dijana Detel, Suncica Buljevic, Lara Baticic Pucar, Natalia Kucic, Ester Pernjak Pugel & Jadranka Varljen. (2016) Influence of CD26/dipeptidyl peptidase IV deficiency on immunophenotypic changes during colitis development and resolution. Journal of Physiology and Biochemistry 72:3, pages 405-419.
Crossref
Tamara Zietek & Eva Rath. (2016) Inflammation Meets Metabolic Disease: Gut Feeling Mediated by GLP-1. Frontiers in Immunology 7.
Crossref
Mark M Smits, Daniel H van Raalte, Lennart Tonneijck, Marcel H A Muskiet, Mark H H Kramer & Djuna L Cahen. (2016) GLP-1 based therapies: clinical implications for gastroenterologists. Gut 65:4, pages 702-711.
Crossref
Yannick Waumans, Lesley Baerts, Kaat Kehoe, Anne-Marie Lambeir & Ingrid De Meester. (2015) The Dipeptidyl Peptidase Family, Prolyl Oligopeptidase, and Prolyl Carboxypeptidase in the Immune System and Inflammatory Disease, Including Atherosclerosis. Frontiers in Immunology 6.
Crossref
Taisuke Sakanaka, Takuya Inoue, Naoki Yorifuji, Munetaka Iguchi, Kaori Fujiwara, Ken Narabayashi, Kazuki Kakimoto, Sadaharu Nouda, Toshihiko Okada, Takanori Kuramoto, Kumi Ishida, Yosuke Abe, Toshihisa Takeuchi, Eiji Umegaki, Yasutada Akiba, Jonathan D Kaunitz & Kazuhide Higuchi. (2015) The effects of a TGR5 agonist and a dipeptidyl peptidase IV inhibitor on dextran sulfate sodium-induced colitis in mice. Journal of Gastroenterology and Hepatology 30, pages 60-65.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.